Search research articles
Contact Us
Filters
Showing results (211-220 of 249) with videos related to
Page
of 25
Sort By:
The Journal of Clinical Psychiatry
|
May 13, 2014
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers
Napatkamon Ayutyanont, Jessica B S Langbaum, Suzanne B Hendrix, et al.
Plos Genetics
|
December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease
Patrick Danoy, Karena Pryce, Johanna Hadler, et al.
Neurology
|
April 27, 2018
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease
Jeffrey L Cummings, Sharon Cohen, Christopher H van Dyck, et al.
Science (New York, N.Y.)
|
December 1, 2022
Active DNA demethylation promotes cell fate specification and the DNA damage response
Dongpeng Wang, Wei Wu, Elsa Callen, et al.
Plos One
|
May 10, 2014
Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors
Jonathan E Nuss, Kylene Kehn-Hall, Ashwini Benedict, et al.
The Lancet Regional Health. Western Pacific
|
July 5, 2022
Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020
Xinning Tong, Xue Li, Nicole L Pratt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Alzheimer'S Research & Therapy
|
September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
Stephen Salloway, Lee A Honigberg, William Cho, et al.
The Journal of Biological Chemistry
|
June 6, 2003
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reesei
Pamela K Foreman, Doug Brown, Lydia Dankmeyer, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2026
Lysosomal escape and TMEM106B fibrillar core determine TDP-43 seeding outcomes
Weijia Zhong, Carlo Scialò, Beatrice Gatta, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 249) with videos related to
Sort By:
Page
of 25
The Journal of Clinical Psychiatry
|
May 13, 2014
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers
Napatkamon Ayutyanont, Jessica B S Langbaum, Suzanne B Hendrix, et al.
Plos Genetics
|
December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease
Patrick Danoy, Karena Pryce, Johanna Hadler, et al.
Neurology
|
April 27, 2018
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease
Jeffrey L Cummings, Sharon Cohen, Christopher H van Dyck, et al.
Science (New York, N.Y.)
|
December 1, 2022
Active DNA demethylation promotes cell fate specification and the DNA damage response
Dongpeng Wang, Wei Wu, Elsa Callen, et al.
Plos One
|
May 10, 2014
Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors
Jonathan E Nuss, Kylene Kehn-Hall, Ashwini Benedict, et al.
The Lancet Regional Health. Western Pacific
|
July 5, 2022
Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020
Xinning Tong, Xue Li, Nicole L Pratt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Alzheimer'S Research & Therapy
|
September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
Stephen Salloway, Lee A Honigberg, William Cho, et al.
The Journal of Biological Chemistry
|
June 6, 2003
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reesei
Pamela K Foreman, Doug Brown, Lydia Dankmeyer, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2026
Lysosomal escape and TMEM106B fibrillar core determine TDP-43 seeding outcomes
Weijia Zhong, Carlo Scialò, Beatrice Gatta, et al.
Page
of 25